Forbion announces €164.5 M for BioEconomy Fund I

Forbion, a venture capital firm focused on biotechnology, has announced that its BioEconomy Fund I has raised €164.5 million, exceeding its initial target of €150 million.

The fund has attracted investments from notable institutional backers, including KfW Capital, Novo Holdings, Rentenbank, and Aurae Impact. New investors ABN AMRO Bank and EIFO also participated.

BioEconomy Fund I aims for a final close near its hard cap of €200 million. The fund emphasizes the commercial potential of biotech innovations addressing global sustainability issues.

Launched in November 2023, the fund focuses on business-to-business (B2B) solutions that provide scalable, cost-effective alternatives to unsustainable products. The fund targets four sectors: Food, Agriculture, Materials, and Environmental Technologies.

Sander Slootweg, Managing Partner of Forbion, highlighted that raising over €150 million in just over a year indicates investor confidence in the firm’s strategy.

- Advertisement -
Ad imageAd image

General Partner Alex Hoffmann noted that investors recognize the potential of scalable biotech solutions to promote sustainable practices and transform industries. Their support aims to enable meaningful change for these companies.

TAGGED:
Share This Article